| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 450.29 | 18.4% | 42.3% |
| Total Income | 451.95 | 17.5% | 40.9% |
| Expenditure | 396.27 | 14.8% | 44.0% |
| PBT | 55.68 | 41.9% | 22.1% |
| Net Profit | 42.15 | 42.1% | 23.2% |
| OPM | 15.41% | 1.78pp | 4.05pp |
| NPM | 9.33% | 1.61pp | 1.33pp |
| EPS | 7.37 | 42.3% | 23.4% |
Innova Captab Ltd Reports 42.3% YoY Revenue Growth and 39.6% EBIDTA Growth in Q3 FY26
23 Jan 2026 · 23 Jan, 3:05 pm
Summary
Innova Captab Ltd, a leading pharmaceutical company, reported strong results for Q3 FY26 with Revenue from Operations at ₹ 450.3 crores and EBIDTA at ₹ 71.1 crores. The company registered YoY Revenue growth of 42.3% and EBIDTA growth of 39.6%.
Key Highlights
- 1
Revenue from Operations registered strong growth of 42% to ₹ 450.3 crores vs. ₹ 316.5 crores
- 2
Recorded EBITDA growth of 40% to ₹ 71.1 crores vs. ₹ 50.9 crores
- 3
EBITDA margin for the quarter was 15.8%
- 4
PAT for the quarter was ₹ 42.1 crores, registering growth of 23%
- 5
PAT margin was 9.4%
- 6
Revenue from Operations for 9M FY26 cumulated to ₹ 1182.2 crores vs. ₹ 928.9 crores in 9M FY25, clocking growth of 27%
- 7
EBITDA for 9M FY26 stood at ₹ 183.7 crores vs. ₹ 147.1 crores in 9M FY25, growing at 25%
- 8
Profit after Tax was ₹ 102.8 crores. PAT margin came in at 8.7%
Management Comments
Mr. Vinay Lohariwala
Innova Captab Ltd delivered accelerated YoY revenue growth of 42% in Q3 FY26 and of 27% in 9M FY26... We remain committed to executing our long- term vision for stakeholder value creation.
Informational and educational content only. Not investment advice.